Ayala Pharmaceuticals Inc. and Lyra Therapeutics Inc. said in US Securities and Exchange Commission (SEC) paperwork filed on the same day that they were gearing up to launch initial public offerings, but the two companies went public a week apart, grossing $55m and $64m, respectively.
Rehovot, Israel- and Wilmington, DE-based Ayala sold 3.67m shares at $15 each on 7 May, pricing the offering in the...






